368
Views
79
CrossRef citations to date
0
Altmetric
Article

Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit

, , , &
Pages 858-863 | Received 26 Jan 2004, Accepted 11 Mar 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

E. S. Björnsson, A. Johannsson, S. S. Sigurdarson, J. P. Hreinsson & V. Runarsdottir. (2023) Development of severe alcohol related liver disease over four decades in Iceland: impact of increased access and use of alcohol. Scandinavian Journal of Gastroenterology 58:12, pages 1523-1533.
Read now
Einar S. Björnsson, Kristjan Hauksson, Ragna Sigurdardottir, Margret Arnardottir, Arnar S. Agustsson, Sigrun H. Lund & Evangelos Kalaitzakis. (2020) Abstinence from alcohol and alcohol rehabilitation therapy in alcoholic liver disease: a population-based study. Scandinavian Journal of Gastroenterology 55:4, pages 472-478.
Read now
Perttu Sahlman, Markku Nissinen, Eero Pukkala & Martti Färkkilä. (2016) Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study. Scandinavian Journal of Gastroenterology 51:8, pages 961-966.
Read now
Pierre Nahon, Angela Sutton, Marianne Ziol, Jessica Zucman-Rossi, Jean-Claude Trinchet & Nathalie Ganne-Carrié. (2015) Genetic Risk Markers for Hepatocellular Carcinoma in Patients with Alcoholic Liver Disease. Hepatic Oncology 2:1, pages 63-78.
Read now
Jonathan Montomoli, Rune Erichsen, Mette Nørgaard, Morten Høyer, Jesper Bach Hansen & Jacob Bonde Jacobsen. (2011) Survival of patients with primary liver cancer in central and northern Denmark, 1998–2009. Clinical Epidemiology 3:sup1, pages 3-10.
Read now
Einar Björnsson, Einar Björnsson, Lars Aabakken, Sigurdur Olafsson & Flemming Bendtsen. (2009) Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries?. Scandinavian Journal of Gastroenterology 44:9, pages 1037-1047.
Read now
John W. Haukeland, Linn T. Schreiner, Inger Lorgen, Svein-Oskar Frigstad, Christina Bang, Nils Raknerud & Zbigniew Konopski. (2008) ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis. Scandinavian Journal of Gastroenterology 43:10, pages 1241-1248.
Read now

Articles from other publishers (72)

Wen Hui Lim, Phoebe Tay, Cheng Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Muthiah, Eunice X. X. Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P. Lee, Philippe Mathurin, Rohit Loomba & Daniel Q. Huang. (2024) Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Alimentary Pharmacology & Therapeutics 59:6, pages 730-741.
Crossref
Manuel Romero-Gómez, Juan Pablo Arab, Claudia P. Oliveira, María Hernández, Marco Arrese, Helena Cortez-Pinto & Ramón Bataller. (2024) Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?. Seminars in Liver Disease 44:01, pages 069-078.
Crossref
Georgios N. Kalambokis, Nikolleta Chouliara, Ilias Tsiakas, Sempastien Filippas-Ntekuan, Maria Christaki, Grigorios Despotis & Haralampos Milionis. (2024) Impact of continued alcohol use on liver-related outcomes of alcohol-associated cirrhosis: a retrospective study of 440 patients. European Journal of Gastroenterology & Hepatology 36:1, pages 89-96.
Crossref
Hersh Shroff & Heather Gallagher. (2023) Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians. Clinical Therapeutics 45:12, pages 1177-1188.
Crossref
Adeline Donati, Jean Henrion, Maxime Regnier, Pierre Deltenre & Astrid Marot. (2023) Abstinence is associated with better outcomes in patients with alcohol-related hepatocellular carcinoma: Results of an observational study. Clinics and Research in Hepatology and Gastroenterology 47:10, pages 102225.
Crossref
Astrid Marot, Jean Henrion, Jean-François Knebel, Eric Trépo, Christophe Moreno & Pierre Deltenre. (2023) A model for individualized prediction of liver-related death in outpatients with alcohol-associated cirrhosis. Hepatology Communications 7:9.
Crossref
Benedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Josef Maria Bauer, Lorenz Balcar, Rafael Paternostro, Philipp Schwabl, Georg Semmler, Bernhard Scheiner, Albert Friedrich Staettermayer, Michael Trauner, Mattias Mandorfer & Thomas Reiberger. (2023) Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis. Clinical Gastroenterology and Hepatology 21:9, pages 2308-2317.e7.
Crossref
Hye Ri Kim, Seung Ho Kim, Yedaun Lee, Jung Hee Son, Eun Joo Park & Ji Hwa Ryu. (2023) Correlation Between Computed Tomography Findings and the Laboratory Test-Derived Severity Score in Patients With Severe Acute Alcoholic Hepatitis. Journal of Computer Assisted Tomography 47:4, pages 548-553.
Crossref
Mark D. Theodoreson, Guruprasad P. Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Ian A. Rowe & Richard Parker. (2023) Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis. Liver International 43:4, pages 763-772.
Crossref
Alexandre Louvet, Valérie Bourcier, Isabelle Archambeaud, Louis d’Alteroche, Cendrine Chaffaut, Frédéric Oberti, Christophe Moreno, Dominique Roulot, Thông Dao, Romain Moirand, Jean-Charles Duclos-Vallée, Odile Goria, Eric Nguyen-Khac, Stanislas Pol, Nicolas Carbonell, Jérôme Gournay, Laure Elkrief, Isabelle Fouchard-Hubert, Sylvie Chevret, Nathalie Ganne-Carrié, Nathalie Ganne-Carrié, Valérie Bourcier, Cendrine Chaffaut, Sylvie Chevret, Isabelle Archambeaud, Jérôme Gournay, Louis d’Alteroche, Laure Elkrief, Frédéric Oberti, Isabelle Fouchard-Hubert, Dominique Roulot, Christophe Moreno, Alexandre Louvet, Thông Dao, Romain Moirand, Jean-Charles Duclos-Vallée, Odile Goria, Eric Nguyen-Khac, Stanislas Pol, Nicolas Carbonell, Jean-Marie Péron, Victor de Lédinghen, Violaine Ozenne, Jean Henrion, Albert Tran, Gabriel Perlemuter, Xavier Amiot & Jean-Pierre Zarski. (2023) Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort. Journal of Hepatology 78:3, pages 501-512.
Crossref
Sebastian Mueller & Johannes Mueller. 2023. Alcohol and Alcohol-related Diseases. Alcohol and Alcohol-related Diseases 81 102 .
Benedikt Silvester Hofer & Thomas Reiberger. 2023. Alcohol and Alcohol-related Diseases. Alcohol and Alcohol-related Diseases 817 830 .
Ashwin D Dhanda, Hannah Allende, Victoria Allgar, Jackie Andrade, Matthew Peter Bailey, Lynne Callaghan, Laura Cocking, Elizabeth Goodwin, Annie Hawton, Christopher Hayward, Ben Hudson, Alison Jeffery, Angela King, Victoria Lavers, Joe Lomax, C Anne McCune, Richard Parker, Christopher Rollinson, Jonny Wilks & E Siobhan Creanor. (2022) Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol. BMJ Open 12:5, pages e060498.
Crossref
Nora V. Bergasa. 2022. Clinical Cases in Hepatology. Clinical Cases in Hepatology 255 293 .
Wei-Che Chiu, Jia-Chi Shan, Yao-Hsu Yang, Vincent Chin-Hung Chen & Pau-Chung Chen. (2021) Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder. Drug and Alcohol Dependence 228, pages 109096.
Crossref
Goran Bokan & Zoran Mavija. (2021) CLIF-C AD score versus MELD score in predicting mortality in alcoholic liver cirrhosis patients. Биомедицинска истраживања 12:2, pages 170-174.
Crossref
Elsa Solà, Elisa Pose, Daniela Campion, Salvatore Piano, Olivier Roux, Macarena Simon-Talero, Frank Uschner, Koos de Wit, Giacomo Zaccherini, Carlo Alessandria, Ulrich Beuers, Paolo Caraceni, Claire Francoz, Rajeshwar P. Mookerjee, Jonel Trebicka, Victor Vargas, Miquel Serra, Ferran Torres, Sara Montagnese, Aleksander Krag, Ruben Hernaez, Marko Korenjak, Hugh Watson, Juan G. Abraldes, Patrick S. Kamath, Pere Ginès, F. Durand, M. Bernardi, C. Solé, J. Pich, I. Graupera, L. Napoleone, C. Jiménez, A. Juanola, E. Avitabile, A. Ma, N. Fabrellas, M. Carol, E. Palacio, M. Aban, T. Lanzillotti, G. Nicolao, M.T. Chiappa, V. Esnault, A. Forner, S. Graf-Dirmeier, J. Helder, M. Lopez, M. Cervera & M. Pérez-Guasch. (2021) Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. Journal of Hepatology 74:1, pages 200-219.
Crossref
Akira Sakamaki, Kunihiko Yokoyama, Kyutaro Koyama, Shinichi Morita, Hiroyuki Abe, Kenya Kamimura, Masaaki Takamura & Shuji Terai. (2020) Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis. PLOS ONE 15:11, pages e0242582.
Crossref
Svetlana Chernyavsky, Patricia Dharapak, Jennifer Hui, Violetta Laskova, Eve Merrill, Kamana Pillay, Evan Siau & Dahlia Rizk. (2020) Alcohol and the Hospitalized Patient. Medical Clinics of North America 104:4, pages 681-694.
Crossref
Giovanni Addolorato, Ludovico Abenavoli, Marcello Dallio, Alessandro Federico, Giacomo Germani, Stefano Gitto, Gioacchino Leandro, Carmelina Loguercio, Fabio Marra & Elisa Stasi. (2020) Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Digestive and Liver Disease 52:4, pages 374-391.
Crossref
Seong Hee Kang, Soon Koo Baik & Moon Young Kim. (2020) Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease. Journal of Korean Medical Science 35:30.
Crossref
Meritxell Ventura‐Cots, Nambi Ndugga & Ramon Bataller. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e 503 522 .
Theresa Hydes, William Gilmore, Nick Sheron & Ian Gilmore. (2019) Treating alcohol-related liver disease from a public health perspective. Journal of Hepatology 70:2, pages 223-236.
Crossref
Nathalie Ganne-Carrié & Pierre Nahon. (2019) Hepatocellular carcinoma in the setting of alcohol-related liver disease. Journal of Hepatology 70:2, pages 284-293.
Crossref
Perry Zong. (2018) Abstinence from alcohol improves survival in decompensated cirrhotic patients. Clinical Research In Practice: The Journal of Team Hippocrates 4:2.
Crossref
Eric Nguyen-Khac, Maja Thiele, Cosmin Voican, Pierre Nahon, Christophe Moreno, Jerome Boursier, Sebastian Mueller, Victor de Ledinghen, Peter Stärkel, Sang Gyune Kim, Michael Fernandez, Bjorn Madsen, Sylvie Naveau, Aleksander Krag, Gabriel Perlemuter, Marianne Ziol, Denis Chatelain & Momar Diouf. (2018) Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. The Lancet Gastroenterology & Hepatology 3:9, pages 614-625.
Crossref
Mark Thursz, Antoni Gual, Caroline Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck & Helena Cortez-Pinto. (2018) EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. Journal of Hepatology 69:1, pages 154-181.
Crossref
Alexandre Louvet, Julien Labreuche, Florent Artru, Alexis Bouthors, Benjamin Rolland, Pierre Saffers, Julien Lollivier, Elise Lemaître, Sébastien Dharancy, Guillaume Lassailly, Valérie Canva‐Delcambre, Alain Duhamel & Philippe Mathurin. (2017) Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. Hepatology 66:5, pages 1464-1473.
Crossref
Maxime Mallet, Marika Rudler & Dominique Thabut. (2017) Variceal bleeding in cirrhotic patients. Gastroenterology Report 5:3, pages 185-192.
Crossref
Tobias Effertz, Frank Verheyen & Roland Linder. (2016) The costs of hazardous alcohol consumption in Germany. The European Journal of Health Economics 18:6, pages 703-713.
Crossref
Astrid Marot, Eric Trépo, Christopher Doerig, Alain Schoepfer, Christophe Moreno & Pierre Deltenre. (2016) Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding. Liver International 37:5, pages 707-716.
Crossref
Jawgam Umbon, Kalpana C & Niranjan G. (2016) A STUDY OF CLINICAL PROFILE AND PROGNOSTIC INDICATORS OF ALCOHOLIC LIVER DISEASE IN A TERTIARY CARE CENTRE OF NORTH EAST INDIA. Journal of Evidence Based Medicine and Healthcare 3:77, pages 4175-4180.
Crossref
Tsung-Hsing Hung, Chen-Chi Tsai, Yu-Hsi Hsieh, Chih-Chun Tsai, Chih-Wei Tseng & Kuo-Chih Tseng. (2016) The Effect of the First Spontaneous Bacterial Peritonitis Event on the Mortality of Cirrhotic Patients with Ascites: A Nationwide Population-Based Study in Taiwan. Gut and Liver 10:5, pages 803-807.
Crossref
Mariusz Piechota & Anna Piechota. (2016) An Evaluation of the Usefulness of Extracorporeal Liver Support Techniques in Patients Hospitalized in the ICU for Severe Liver Dysfunction Secondary to Alcoholic Liver Disease. Hepatitis Monthly 16:7.
Crossref
Hiroshi Fukui, Hidetsugu Saito, Yoshiyuki Ueno, Hirofumi Uto, Katsutoshi Obara, Isao Sakaida, Akitaka Shibuya, Masataka Seike, Sumiko Nagoshi, Makoto Segawa, Hirohito Tsubouchi, Hisataka Moriwaki, Akinobu Kato, Etsuko Hashimoto, Kojiro Michitaka, Toshikazu Murawaki, Kentaro Sugano, Mamoru Watanabe & Tooru Shimosegawa. (2016) Evidence-based clinical practice guidelines for liver cirrhosis 2015. Journal of Gastroenterology 51:7, pages 629-650.
Crossref
Perttu Sahlman, Markku Nissinen, Eero Pukkala & Martti Färkkilä. (2016) Cancer incidence among alcoholic liver disease patients in F inland: A retrospective registry study during years 1996–2013 . International Journal of Cancer 138:11, pages 2616-2621.
Crossref
Jan Petrasek & Gyongyi Szabo. 2016. Alcoholic and Non-Alcoholic Fatty Liver Disease. Alcoholic and Non-Alcoholic Fatty Liver Disease 291 311 .
Jose Altamirano, Eric S. Orman & Ramon Bataller. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 2043 2055 .
Nicolas Goossens. (2015) Molecular prognostic prediction in liver cirrhosis. World Journal of Gastroenterology 21:36, pages 10262.
Crossref
M. Roerecke & J. Rehm. (2014) Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. International Journal of Epidemiology 43:3, pages 906-919.
Crossref
Yan‐Di Xie, Bo Feng, Yan Gao & Lai Wei. (2013) Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: A systematic review and meta‐analysis. Hepatology Research 44:4, pages 436-449.
Crossref
Jer-Hwa Hsu, I-Chia Chien, Ching-Heng Lin, Yiing-Jenq Chou & Pesus Chou. (2014) Increased Risk of Chronic Liver Disease in Patients with Schizophrenia: A Population-Based Cohort Study. Psychosomatics 55:2, pages 163-171.
Crossref
Steven Masson, Ingrid Emmerson, Elsbeth Henderson, Emma H. Fletcher, Alastair D. Burt, Christopher P. Day & Stephen F. Stewart. (2013) Clinical but not histological factors predict long‐term prognosis in patients with histologically advanced non‐decompensated alcoholic liver disease. Liver International 34:2, pages 235-242.
Crossref
Aloysious Aravinthan, Giada Pietrosi, Matthew Hoare, James Jupp, Aileen Marshall, Clare Verrill, Susan Davies, Adrian Bateman, Nick Sheron, Michael Allison & Graeme J. M. Alexander. (2013) Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease. PLoS ONE 8:9, pages e72904.
Crossref
Michael Roerecke & Jürgen Rehm. (2013) Alcohol use disorders and mortality: a systematic review and meta‐analysis. Addiction 108:9, pages 1562-1578.
Crossref
Sudul Mananjala Senanayake, Madunil Anuk Niriella, Sanjaya Kumara Weerasinghe, Anuradhani Kasturiratne, Jerome Praneeth de Alwis, Arjuna Priyadarsin de Silva, Anuradha Supun Dassanayake & Hithanadura Janaka de Silva. (2012) Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study. BMC Research Notes 5:1.
Crossref
. (2012) EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. Journal of Hepatology 57:2, pages 399-420.
Crossref
J. Wiegand, M. Kühne, P. Pradat, J. Mössner, C. Trepo & H. L. Tillmann. (2012) Different patterns of decompensation in patients with alcoholic vs. non‐alcoholic liver cirrhosis. Alimentary Pharmacology & Therapeutics 35:12, pages 1443-1450.
Crossref
Ruth Weissenborn & David J Nutt. (2011) Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?. Journal of Psychopharmacology 26:2, pages 213-220.
Crossref
Madhava Pai, Duncan Spalding, Feng Xi & Nagy Habib. (2012) Autologous Bone Marrow Stem Cells in the Treatment of Chronic Liver Disease. International Journal of Hepatology 2012, pages 1-7.
Crossref
Marco Antonio Alvarez, Isabel Cirera, Ricard Solà, Ana Bargalló, Rosa Maria Morillas & Ramon Planas. (2011) Long-term Clinical Course of Decompensated Alcoholic Cirrhosis. Journal of Clinical Gastroenterology 45:10, pages 906-911.
Crossref
Evangelos Kalaitzakis, Steingerdur Anna Gunnarsdottir, Axel Josefsson & Einar Björnsson. (2011) Increased Risk for Malignant Neoplasms Among Patients With Cirrhosis. Clinical Gastroenterology and Hepatology 9:2, pages 168-174.
Crossref
Knut Stokkeland, Fereshte Ebrahim & Anders Ekbom. (2010) Increased Risk of Esophageal Varices, Liver Cancer, and Death in Patients With Alcoholic Liver Disease. Alcoholism: Clinical and Experimental Research 34:11, pages 1993-1999.
Crossref
Peter Jepsen, Peter Ott, Per Kragh Andersen, Henrik Toft Sørensen & Hendrik Vilstrup. (2010) Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study. Hepatology 51:5, pages 1675-1682.
Crossref
Nobuyuki Toshikuni, Akiyoshi Izumi, Ken Nishino, Nobu Inada, Ritsuko Sakanoue, Ryumei Yamato, Mitsuhiko Suehiro, Miwa Kawanaka & Gotaro Yamada. (2009) Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus‐related cirrhosis. Journal of Gastroenterology and Hepatology 24:7, pages 1276-1283.
Crossref
Clare Verrill, Hannah Markham, Alexa Templeton, Norman J. Carr & Nick Sheron. (2009) Alcohol‐related cirrhosis—early abstinence is a key factor in prognosis, even in the most severe cases. Addiction 104:5, pages 768-774.
Crossref
P.L.M. Jansen. 2009. Leverziekten. Leverziekten 127 132 .
Evangelos Kalaitzakis, Jesper Wallskog & Einar Björnsson. (2008) Abstinence in patients with alcoholic liver cirrhosis: A follow‐up study. Hepatology Research 38:9, pages 869-876.
Crossref
Madhava Pai, Dimitris Zacharoulis, Miroslav N. Milicevic, Salah Helmy, Long R. Jiao, Nataša Levičar, Paul Tait, Michael Scott, Stephen B. Marley, Kevin Jestice, Maria Glibetic, Devinder Bansi, Shahid A. Khan, Despina Kyriakou, Christos Rountas, Andrew Thillainayagam, Joanna P. Nicholls, Steen Jensen, Jane F. Apperley, Myrtle Y. Gordon & Nagy A. Habib. (2008) Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis. The American Journal of Gastroenterology 103:8, pages 1952-1958.
Crossref
Michael R. Lucey, Jason T. Connor, Thomas D. Boyer, J. Michael Henderson & Layton F. Rikkers. (2008) Alcohol Consumption by Cirrhotic Subjects: Patterns of Use and Effects on Liver Function. The American Journal of Gastroenterology 103:7, pages 1698-1706.
Crossref
Peter Jepsen, Hendrik Vilstrup, Per Kragh Andersen, Timothy L. Lash & Henrik Toft Sørensen. (2008) Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort study. Hepatology 48:1, pages 214-220.
Crossref
J.-S. Bladé, J. Desramé, D. Corberand, S. Lecoules, H. Blondon, T. Carmoi, M. Zyani, D. Béchade & J.-P. Algayres. (2007) Diagnostic des anémies au cours des cirrhoses alcooliques. La Revue de Médecine Interne 28:11, pages 756-765.
Crossref
Laurent Spahr, Emiliano Giostra, Jean-Louis Frossard, Isabelle Morard, Gilles Mentha & Antoine Hadengue. (2007) A 3-Month Course of Long-Acting Repeatable Octreotide (Sandostatin LAR) Improves Portal Hypertension in Patients With Cirrhosis: A Randomized Controlled Study. The American Journal of Gastroenterology 102:7, pages 1397-1405.
Crossref
Laurent Spahr & Antoine Hadengue. 2007. Textbook of Hepatology. Textbook of Hepatology 1157 1178 .
Hakim Fassi-Fehri, Youssef Zakaria, Jean-Marie Marechal, Guillaume Marcotte, Marc Colombel, Xavier Martin & Lionel Badet. (2007) Néphrectomie élargie gauche chez deux patients atteints d’hypertension portale porteurs d’un shunt veineux spléno-rénal. Progrès en Urologie 17:1, pages 101-104.
Crossref
Igor Dvorchik & Brian I. Carr. (2007) A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization. Cancer Detection and Prevention 31:2, pages 154-160.
Crossref
S. Hwang, S.G. Lee, K.K. Kim, K.H. Kim, C.S. Ahn, D.B. Moon, T.Y. Ha & G.W. Song. (2006) Efficacy of 6-Month Pretransplant Abstinence for Patients With Alcoholic Liver Disease Undergoing Living Donor Liver Transplantation. Transplantation Proceedings 38:9, pages 2937-2940.
Crossref
Nathan M. Bass, Bernard C. Portmann & Michael R. Lucey. (2006) Abnormal liver function tests in the patient transplanted 3 years ago for alcoholic liver disease. Liver Transplantation 12:S2, pages S76-S82.
Crossref
A. GRAMENZI, F. CAPUTO, M. BISELLI, F. KURIA, E. LOGGI, P. ANDREONE & M. BERNARDI. (2006) Review article: alcoholic liver disease – pathophysiological aspects and risk factors. Alimentary Pharmacology & Therapeutics 24:8, pages 1151-1161.
Crossref
STEWART SMITH, JOANNA WHITE, CHRIS NELSON, MARIANNE DAVIES, JOANNE LAVERS & NICK SHERON. (2006) SEVERE ALCOHOL-INDUCED LIVER DISEASE AND THE ALCOHOL DEPENDENCE SYNDROME. Alcohol and Alcoholism 41:3, pages 274-277.
Crossref
Gennaro D'Amico, Guadalupe Garcia-Tsao & Luigi Pagliaro. (2006) Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. Journal of Hepatology 44:1, pages 217-231.
Crossref
Ira R Willner & Adrian Reuben. (2005) Alcohol and the liver. Current Opinion in Internal Medicine 4:4, pages 367-374.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.